Frameworks for Proof-of-Concept Clinical Trials of Interventions That Target Fundamental Aging Processes

Jamie Justice, Jordan D Miller, John C. Newman, Shahrukh K. Hashmi, Jeffrey Halter, Steve N. Austad, Nir Barzilai, James L Kirkland

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Therapies targeted at fundamental processes of aging may hold great promise for enhancing the health of a wide population by delaying or preventing a range of age-related diseases and conditions - a concept dubbed the "geroscience hypothesis." Early, proof-of-concept clinical trials will be a key step in the translation of therapies emerging from model organism and preclinical studies into clinical practice. This article summarizes the outcomes of an international meeting partly funded through the NIH R24 Geroscience Network, whose purpose was to generate concepts and frameworks for early, proof-of-concept clinical trials for therapeutic interventions that target fundamental processes of aging. The goals of proof-of-concept trials include generating preliminary signals of efficacy in an aging-related disease or outcome that will reduce the risk of conducting larger trials, contributing data and biological samples to support larger-scale research by strategic networks, and furthering a dialogue with regulatory agencies on appropriate registration indications. We describe three frameworks for proof-of-concept trials that target age-related chronic diseases, geriatric syndromes, or resilience to stressors. We propose strategic infrastructure and shared resources that could accelerate development of therapies that target fundamental aging processes.

Original languageEnglish (US)
Pages (from-to)1415-1423
Number of pages9
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume71
Issue number11
DOIs
StatePublished - Nov 1 2016

Fingerprint

Clinical Trials
Therapeutics
Geriatrics
Chronic Disease
Health
Research
Population
Clinical Studies

Keywords

  • Aging
  • Clinical trials
  • Geroscience Network

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Cite this

Frameworks for Proof-of-Concept Clinical Trials of Interventions That Target Fundamental Aging Processes. / Justice, Jamie; Miller, Jordan D; Newman, John C.; Hashmi, Shahrukh K.; Halter, Jeffrey; Austad, Steve N.; Barzilai, Nir; Kirkland, James L.

In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 71, No. 11, 01.11.2016, p. 1415-1423.

Research output: Contribution to journalArticle

Justice, Jamie ; Miller, Jordan D ; Newman, John C. ; Hashmi, Shahrukh K. ; Halter, Jeffrey ; Austad, Steve N. ; Barzilai, Nir ; Kirkland, James L. / Frameworks for Proof-of-Concept Clinical Trials of Interventions That Target Fundamental Aging Processes. In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2016 ; Vol. 71, No. 11. pp. 1415-1423.
@article{4aafbe8fc6994a7280058d9b15cd0195,
title = "Frameworks for Proof-of-Concept Clinical Trials of Interventions That Target Fundamental Aging Processes",
abstract = "Therapies targeted at fundamental processes of aging may hold great promise for enhancing the health of a wide population by delaying or preventing a range of age-related diseases and conditions - a concept dubbed the {"}geroscience hypothesis.{"} Early, proof-of-concept clinical trials will be a key step in the translation of therapies emerging from model organism and preclinical studies into clinical practice. This article summarizes the outcomes of an international meeting partly funded through the NIH R24 Geroscience Network, whose purpose was to generate concepts and frameworks for early, proof-of-concept clinical trials for therapeutic interventions that target fundamental processes of aging. The goals of proof-of-concept trials include generating preliminary signals of efficacy in an aging-related disease or outcome that will reduce the risk of conducting larger trials, contributing data and biological samples to support larger-scale research by strategic networks, and furthering a dialogue with regulatory agencies on appropriate registration indications. We describe three frameworks for proof-of-concept trials that target age-related chronic diseases, geriatric syndromes, or resilience to stressors. We propose strategic infrastructure and shared resources that could accelerate development of therapies that target fundamental aging processes.",
keywords = "Aging, Clinical trials, Geroscience Network",
author = "Jamie Justice and Miller, {Jordan D} and Newman, {John C.} and Hashmi, {Shahrukh K.} and Jeffrey Halter and Austad, {Steve N.} and Nir Barzilai and Kirkland, {James L}",
year = "2016",
month = "11",
day = "1",
doi = "10.1093/gerona/glw126",
language = "English (US)",
volume = "71",
pages = "1415--1423",
journal = "Journals of Gerontology - Series A Biological Sciences and Medical Sciences",
issn = "1079-5006",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Frameworks for Proof-of-Concept Clinical Trials of Interventions That Target Fundamental Aging Processes

AU - Justice, Jamie

AU - Miller, Jordan D

AU - Newman, John C.

AU - Hashmi, Shahrukh K.

AU - Halter, Jeffrey

AU - Austad, Steve N.

AU - Barzilai, Nir

AU - Kirkland, James L

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Therapies targeted at fundamental processes of aging may hold great promise for enhancing the health of a wide population by delaying or preventing a range of age-related diseases and conditions - a concept dubbed the "geroscience hypothesis." Early, proof-of-concept clinical trials will be a key step in the translation of therapies emerging from model organism and preclinical studies into clinical practice. This article summarizes the outcomes of an international meeting partly funded through the NIH R24 Geroscience Network, whose purpose was to generate concepts and frameworks for early, proof-of-concept clinical trials for therapeutic interventions that target fundamental processes of aging. The goals of proof-of-concept trials include generating preliminary signals of efficacy in an aging-related disease or outcome that will reduce the risk of conducting larger trials, contributing data and biological samples to support larger-scale research by strategic networks, and furthering a dialogue with regulatory agencies on appropriate registration indications. We describe three frameworks for proof-of-concept trials that target age-related chronic diseases, geriatric syndromes, or resilience to stressors. We propose strategic infrastructure and shared resources that could accelerate development of therapies that target fundamental aging processes.

AB - Therapies targeted at fundamental processes of aging may hold great promise for enhancing the health of a wide population by delaying or preventing a range of age-related diseases and conditions - a concept dubbed the "geroscience hypothesis." Early, proof-of-concept clinical trials will be a key step in the translation of therapies emerging from model organism and preclinical studies into clinical practice. This article summarizes the outcomes of an international meeting partly funded through the NIH R24 Geroscience Network, whose purpose was to generate concepts and frameworks for early, proof-of-concept clinical trials for therapeutic interventions that target fundamental processes of aging. The goals of proof-of-concept trials include generating preliminary signals of efficacy in an aging-related disease or outcome that will reduce the risk of conducting larger trials, contributing data and biological samples to support larger-scale research by strategic networks, and furthering a dialogue with regulatory agencies on appropriate registration indications. We describe three frameworks for proof-of-concept trials that target age-related chronic diseases, geriatric syndromes, or resilience to stressors. We propose strategic infrastructure and shared resources that could accelerate development of therapies that target fundamental aging processes.

KW - Aging

KW - Clinical trials

KW - Geroscience Network

UR - http://www.scopus.com/inward/record.url?scp=84994418099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994418099&partnerID=8YFLogxK

U2 - 10.1093/gerona/glw126

DO - 10.1093/gerona/glw126

M3 - Article

C2 - 27535966

AN - SCOPUS:84994418099

VL - 71

SP - 1415

EP - 1423

JO - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

JF - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

SN - 1079-5006

IS - 11

ER -